Let’s start up with the current stock price of DermTech Inc. (DMTK), which is $5.59 to be very precise. The Stock rose vividly during the last session to $5.62 after opening rate of $4.60 while the lowest price it went was recorded $4.56 before closing at $4.52.Recently in News on January 23, 2023, DermTech Adds Approximately 1.2 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT). DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced favorable coverage policies from two commercial payers comprising a Blues plan in Hawaii and a physician-founded, member-focused and community-based not-for-profit health plan in New York. The coverage policies resulted from an independent technology assessment by the second largest laboratory benefits manager in the U.S. and are similar to the Medicare coverage policy of the Company’s foundational assay included in the DermTech Melanoma Test (DMT). You can read further details here
DermTech Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.91 on 01/17/23, with the lowest value was $1.81 for the same time period, recorded on 01/03/23.
DermTech Inc. (DMTK) full year performance was -57.33%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, DermTech Inc. shares are logging -65.77% during the 52-week period from high price, and 260.65% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.55 and $16.33.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1502017 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the DermTech Inc. (DMTK) recorded performance in the market was 215.82%, having the revenues showcasing 75.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 162.11M, as it employees total of 255 workers.
Market experts do have their say about DermTech Inc. (DMTK)
During the last month, 0 analysts gave the DermTech Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.33, with a change in the price was noted +0.17. In a similar fashion, DermTech Inc. posted a movement of +3.14% for the period of last 100 days, recording 635,426 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DMTK is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of DermTech Inc. (DMTK)
Raw Stochastic average of DermTech Inc. in the period of last 50 days is set at 92.66%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 92.66%. In the last 20 days, the company’s Stochastic %K was 74.92% and its Stochastic %D was recorded 68.81%.
Bearing in mind the latest performance of DermTech Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 215.82%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -22.79%, alongside a downfall of -57.33% for the period of the last 12 months. The shares increased approximately by 16.46% in the 7-day charts and went down by 203.80% in the period of the last 30 days. Common stock shares were driven by 75.79% during last recorded quarter.